← Back to headlines
Merck Ebola Vaccine, Gilead Antiviral Drug Set for Wider Use in Congo Outbreak
Merck & Co.’s Ebola vaccine and an antiviral drug from Gilead Sciences Inc. are slated for expanded deployment in eastern Democratic Republic of Congo to combat the rapidly growing Ebola outbreak.
7 Aug, 03:07 — 7 Aug, 03:07
